REFERENCES
-
Loo, T.J., et al.: Mechanism of action and pharmacology studies with DTIC (NSC-45388). Cancer Treatment Reports 60: 149-152, 1976.
-
Nathanson, L., et al.: Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma. Clinical Pharmacology and Therapeutics 12: 955-962, 1971.
-
Costanza, M.E., et al.: Therapy of malignant melanoma with an imidazole carboxamide and bischloroethyl nitrosourea. Cancer 30: 1457-1461, 1972.
-
Luce, J.K., et al.: Clinical trials with the antitumor agent 5-(3, 3-dimethyl-l-triazeno) imidazole-4-carboxamide (NSC-45388). Cancer Chemotherapy Reports 54: 119-124, 1970.
-
Bonadonna, G., et al.: Combined Chemotherapy (MOPP or ABVD)--radiotherapy approach in advanced Hodgkin's disease. Cancer Treatment Reports 61: 769-777, 1977.
-
Santoro, A., and Bonadonna, G.: Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Cancer Chemotherapy Pharmacol. 2: 101-105, 1979.
-
Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs. NIH Publication No. 83-2621. For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.
-
AMA Council Report. Guidelines for Handling Parenteral Antineoplastics. JAMA, March 15, 1985.
-
National Study Commission on Cytotoxic Exposure--Recommendations for Handling Cytotoxic Agents. Available from Louis P. Jeffrey, Sc. D., Director of Pharmacy Services, Rhode Island Hospital, 593 Eddy Street, Providence, Rhode Island 02902.
-
Clinical Oncological Society of Australia: Guidelines and recommendations for safe handling of antineoplastic agents. Med. J. Australia 1: 426-428, 1983.
-
Jones, R.B., et al.: Safe handling of chemotherapeutic agents: A report from the Mount Sinai Medical Center. Ca-A Cancer Journal for Clinicians Sept./Oct. 258-263, 1983.
-
American Society of Hospital Pharmacists technical assistance bulletin on handling cytotoxic drugs in hospitals. Am. J. Hosp. Pharm. 42: 131-137, 1985.
Manufactured by:
Ben Venue Laboratories
Bedford, Ohio 44146
Distributed by:
Bayer Pharmaceuticals Corporation
400 Morgan Lane
West Haven, CT 06516 USA
Rx Only
08844898, R.O5/0311778
© 2003 Bayer Pharmaceuticals Corporation
|